| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 86,642 | 78,626 | 69,176 | 80,867 | | Cost of Revenue | 19,318 | 12,840 | 25,028 | 68,378 | | | Gross Profit | 67,324 | 65,786 | 44,148 | 12,489 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,193 | 22,195 | 10,528 | 1,184 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 11,026 | 7,905 | 9,480 | 19,958 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 39,105 | 35,686 | 24,140 | (8,653) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,671 | 118,363 | 83 | 87,227 | | Earnings Before Interest And Taxes | (366,696) | 154,049 | 24,223 | 78,574 | | Interest Expense | 4,114 | 5,362 | 6,836 | (24,931) | | Income Before Tax | (370,810) | 148,687 | 17,387 | 103,505 | | Income Tax Expense | 15,299 | 55,497 | 6,410 | 38,354 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,363 | 93,190 | 10,977 | 65,151 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,363 | 93,190 | 10,977 | 65,151 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,363 | $93,190 | $10,977 | $65,151 |
|
0.51% Nasdaq 
Income Statement
